Vitolo, U., Duell, J., Burgues, J. M. B., Jurczak, W., Kwiatek, M., Maerevoet, M., Alcaide, S. O., Belada, D., Kim, W. S., Greil, R., Córdoba, R., Sancho, J., Sibon, D., Thieblemont, C., Kumode, T., Wielgos-Bonvallet, M., Jiang, T., Wang, Y., McGoldrick, S., Guo, E., Morschhauser, F., Woei-A-Jin, S. (2025). Fixed-duration epcoritamab monotherapy induces high response and MRD-negativity rates in elderly patients with newly diagnosed large B-cell lymphoma (LBCL) and comorbidities: Results from EPCORE DLBCL-3. Blood. https://doi.org/10.1182/blood-2025-63